Factors specific to retatrutide that might affect real-world outcomes include: The higher side effect rate could drive more discontinuations The heart rate increase might concern prescribers and lead to lower maintenance doses If pricing is higher than tirzepatide, cost barriers could limit access and adherence The more complex triple-agonist mechanism may require more careful monitoring, adding burden Conversely, the additional metabolic benefits (liver fat reduction, possibly better muscle preservation) might improve adherence by providing visible results beyond scale weight, motivating continued use
To increase the plasma half-life by avoiding renal elimination, GLP-1 analogs were modified by adding acyl groups (liraglutide and semaglutide) or large molecules such as albumin (albiglutide) and the Fc portion of IgG (dulaglutide)
If you are considering stopping, talk with your doctor so that any insulin or tablets can be adjusted safely
For me, that meant staying on 5 mg of Zepbound for nearly a year because it continued to control my appetite, quiet my food noise, and help me make healthier choicesall while keeping my side effects very manageable
GLP1 agents may modestly reduce cholecystokininmediated gallbladder contraction after eating, compounding the effect of caloric deficit
Tissues of neuroendocrine origin (brain, testis, adrenal gland, and thyroid) were excluded from this filtering